Tessera Therapeutics
Ryan Alberry serves as a Senior Research Associate at Tessera Therapeutics since August 2019, having progressed through roles including Research Associate II and Research Associate. Prior experience includes a position as a Laboratory Technician at the University of Massachusetts Boston from October 2014 to January 2020, where responsibilities encompassed ensuring the operation of biology teaching labs, supervising undergraduate employees, and performing various laboratory techniques such as PCR, SDS-PAGE, and DNA extraction. Ryan also worked as a tutor for chemistry, physics, and calculus. Educational qualifications include a Postbaccalaureate in Mathematics from Brandeis University (2017-2018), a Bachelor of Science in Biochemistry from UMass Boston (2014-2016), and an Associate's degree from Lake-Sumter State College (2011-2014).
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.